News

Sickle Cell Disease News1d
Gene-editing therapy may cut stroke risk in SCD, small study finds
The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke ...
Sickle Cell Disease News3d
Dosing started in Phase 1 study of globin-switching therapy CLY-124
The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for ...
sicklecellanemianews3d
Dosing started in Phase 1 study of novel SCD therapy CLY-124
The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for sickle cell disease.